About Mubadala Health
Mubadala Health is the integrated healthcare network of Mubadala Investment Company. Established in 2021, Mubadala Health operates, manages, and develops a portfolio of healthcare assets including: Cleveland Clinic Abu Dhabi, Healthpoint, Imperial College London Diabetes Centre (ICLDC), Amana Healthcare, National Reference Laboratory (NRL), Capital Health Screening Centre (CHSC), Abu Dhabi Telemedicine Centre (ADTC), Danat Al Emarat, HealthPlus Diabetes & Endocrinology Center, HealthPlus Family Clinics, HealthPlus Fertility, HealthPlus Women’s Health Center, and Moorfields Eye Hospital Abu Dhabi.
It was our honor to sign a contract with MUBADALA Health in Abu Dhabi to be a partner in developing the Assessment Rooms in Imperial College London Diabetic Center and Health Point Hospital, by applying MESI m-Tablet for PAD screening
The diagnosis and treatment of virtually any disease should be prompt and comprehensive, especially if it is of cardiovascular nature. This should come as no surprise given the potential deleterious effects of cardiac issues on the entire health and well-being, yet there are also a number of vascular conditions which, if diagnosed late (or not at all), can have serious and even terminal consequences for the affected individual. One of the most prominent of those is peripheral artery disease (PAD).
